5:00am PDT - October 6th, 2022

“Tsunami of Studies” Establishes the Role of Immunotherapy +/- Chemotherapy in Advanced NSCLC Without an Oncogenic Driver: @CoreyLangerMD Discusses Selecting Patients for Immunotherapy & Other Important #LCSM Updates from #ASCO22 https://t.co/pGEShxXp0w

0 retweets   0 likes  - Total Health | Oncology (@TotalHealthConf)